Biotechnology

Gannex Filed US IND for Its NASH Drug ASC42, an FXR Agonist

SHANGHAI, Sept. 14, 2020 /PRNewswire/ -- Gannex Pharma Co., Ltd., a wholly owned company of Ascletis Pharma Inc. (HKEX:1672) announces today that it has filed investigational new drug application (IND) with US FDA for its non-alcoholic steatohepatitis (NASH) drug candidate ASC42. ASC42 is an in-...

2020-09-14 08:30 3735

Virtual reality startup and Fujitsu bring immersive drug design software to Japanese market

SAN DIEGO, Sept. 14, 2020 /PRNewswire/ -- San Diego–based virtual reality (VR) startup Nanome, Inc. has entered into an agreement with Fujitsu to bring their signature product—an immersive scientific design and collaboration platform—to the Japanese market. The software is already used by more th...

2020-09-14 08:17 3563

Haoma Medica Announces Plenary Presentation for NaQuinate, a Potential Novel Treatment for Osteoporosis, at ASBMR 2020 Annual Meeting

LONDON, Sept. 12, 2020 /PRNewswire/ -- Haoma Medica announced a presentation made today at the 2020 American Society for Bone and Mineral Research: Dr Andrew Pitsillides, Professor of Skeletal Dynamics at the Royal Veterinary College, London presented 'NaQuinate: A Drug that Selectively Synergize...

2020-09-12 05:00 6353

Harbour BioMed and Hualan Genetic Announced Collaboration to Develop Multiple Innovative Antibody Programs

CAMBRIDGE, Mass., ROTTERDAM, Netherlands, SUZHOU,China and XINXIANG, China, Sept. 11, 2020 /PRNewswire/ -- Harbour BioMed (HBM), a global, clinical-stage, innovative biopharmaceutical company today announced a strategic partnership agreement with Hualan Genetic Engineering Co., Ltd (Hualan Geneti...

2020-09-11 21:33 7603

Sai Life Sciences expands suite of cellular analysis platforms in Cambridge, MA

CAMBRIDGE, Mass. and HYDERABAD, India, Sept. 11, 2020 /PRNewswire/ --  Sai Life Sciences, one ofIndia's fastest growing Contract Development & Manufacturing Organizations (CDMOs) , today ann...

2020-09-11 11:30 4406

Seneca Biopharma, Inc. Announces Completion of Phase II Clinical Study in China for the Treatment of Ischemic Stroke

GERMANTOWN, Maryland, Sept. 10, 2020 /PRNewswire/ -- Seneca Biopharma, Inc. (Nasdaq: SNCA), a biopharmaceutical company focused on developing novel treatments for diseases of high unmet medical need, today announced that the last subject completed their final follow-up assessment in the Company's...

2020-09-10 20:00 3515

Venus Medtech Taps into Surgical Heart Valve Market by Cooperating with Haoyue Group to Develop the Business of High-end Biomaterial Medical Devices

HANGZHOU, China, Sept. 10, 2020 /PRNewswire/ -- The leading transcatheter heart valve medical device player inChina - Venus Medtech (Hangzhou) Inc. ("Venus Medtech" or the "Company", together with its subsidiaries, the "Group", stock code: 2500) andJilin Changchun Haoyue Halal Meat Co., Ltd ("Hao...

2020-09-10 17:56 10292

Haoma Medica to Present Scientific Data on NaQuinate, a Potential New Treatment for Osteoporosis, at ASBMR 2020 Annual Meeting

LONDON, Sept. 10, 2020 /PRNewswire/ -- Haoma Medica announced today that it will present three scientific posters on NaQuinate at the American Society for Bone and Mineral Research (ASBMR) 2020 Annual Meeting, which this year takes place as a virtual event from the 11-15 September. NaQuinate, a n...

2020-09-10 17:34 3362

The Biofactory Unveils New "Plug and Play" System Capable of Instantly Isolating Healthcare Facilities

SINGAPORE, Sept. 10, 2020 /PRNewswire/ -- The Biofactory, a Singapore-based biomedical technology manufacturer, unveiled a new portable "plug and play" system to isolate positively pressured healthcare facilities (Operating Theatres, Procedure Rooms and Intensive Care Units) and normal pressur...

2020-09-10 09:00 4494

DiscGenics Appoints Former Medtronic Spine and Biologics Finance Executive as First Chief Financial Officer

SALT LAKE CITY, Sept. 10, 2020 /PRNewswire/ -- DiscGenics, Inc., a clinical stage biopharmaceutical company developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced it has appointed former Medtronic ...

2020-09-10 08:30 2622

Tennis Champion Caroline Wozniacki and UCB Launch Advantage Hers Campaign for Women with Chronic Inflammatory Diseases

- Grand Slam winner Caroline Wozniacki is the highest-ranking female athlete known to have been diagnosed with rheumatoid arthritis whilst still playing professional tennis - Advantage Hers will equip and empower women around the world living with chronic inflammatory diseases, such as rheumatoi...

2020-09-09 14:38 2823

TOPADUR Pharma AG Selected CDD Vault Platform to Manage Its Chemistry and Biological Research Data

ZURICH-SCHLIEREN, Switzerland, Sept. 9, 2020 /PRNewswire/ -- TOPADUR Pharma AG, a clinical stage biopharmaceutical start-up company developing new dual-mode of action drugs that target the cGMP-enzyme regulation system, today announces that it has implementedCDD Vault. The company's results from ...

2020-09-09 14:00 2393

Seegene introduces a High-throughput 8-plex Test for Flu A, Flu B, RSV and COVID-19 with dual internal controls

SEOUL, South Korea, Sept. 8, 2020 /PRNewswire/ -- Seegene, Inc. introduced a single tube real-time RT-PCR assay, Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay, which simultaneously detects and differentiates Flu A, Flu B, RSV A/B, and three different target genes of COVID-19 (S gene, RdRP gene and N ge...

2020-09-08 20:00 3096

Ascentage Pharma's Bcl-2 Inhibitor APG-2575 Granted Orphan Drug Designation by the FDA for the Treatment of Chronic Lymphocytic Leukemia

SUZHOU, China and ROCKVILLE, Md., Sept. 7, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the US Food and Drug A...

2020-09-07 17:16 2611

Polygiene ViralOff proven effective against SARS-CoV-2

STOCKHOLM, Sept. 7, 2020 /PRNewswire/ -- In the first test ever using the ISO method* on the SARS-CoV-2 virus on textiles, Polygiene ViralOff® was confirmed the first commercial textiles treatment in the world to reduce the virus by over 99% over two hours. While this comes as no surprise to us, ...

2020-09-07 14:23 2719

RhoVac appoints Professor Georg Hollaender to its Scientific Advisory Board

STOCKHOLM, Sept. 4, 2020 /PRNewswire/ -- RhoVac AB ("RhoVac") announces today September 4th 2020,  that it is continuing to strengthen the Scientific Advisory Board with a pediatric immunologist, by appointing ProfessorGeorg Hollaender, Action Research Professor and Head of Department at Oxford ...

2020-09-04 17:35 3878

Concept Medical announces enrolment of index patient in the crucial Transform -1 RCT using MagicTouch sirolimus coated balloon for small coronary vessels

COTIGNOLA, Italy, Sept. 3, 2020 /PRNewswire/ -- Concept Medical Inc ., focused on vascular intervention drug delivery devices, has announced the enrolment of the first patient in the TRANSFORM-1

2020-09-03 00:55 4184

George Clinical Adds CRO Business Development and Operations Veteran to Lead Efforts in China

OVERLAND PARK, Kansas, Sept. 3, 2020 /PRNewswire/ -- George Clinical, a global scientifically-backed clinical research organization, has expanded the organization's team inChina with the addition of Dr. Zhenfei Yin in the role of Country Head and Regional Head of Project Operations.  Zhenfei will...

2020-09-03 00:00 3527

BOI Says Investors Show Increasing Interest in Thailand's Medical Sector

BANGKOK, Sept. 2, 2020 /PRNewswire/ -- A growing number of international and Thai companies are investing inThailand's medical to help address the COVID-19 situation as well as to build on the country's potential as a medical hub, the Thailand's Board of Investment (BOI) said.

2020-09-02 17:35 4732

Humoral immune response to SARS-CoV2 in Iceland

Titers of antibodies against SARS-CoV2 do not decline within four months REYKJAVIK, Iceland, Sept. 2, 2020 /PRNewswire/ -- Scientists at deCODE genetics inIceland, a subsidiary of Amgen Inc , biopharmaceutical company headquartered inCalifornia, and their collaborators, today publish a study in ...

2020-09-02 05:00 3526
1 ... 156157158159160161162 ... 177